Wilson James N sold 7,221 shares of CORCEPT THERAPEUTICS INC at $72.87 for −$526k on Nov 13, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$526,169.72Shares × reported price
Shares traded
7,221Common Stock
Price per share
$72.87Reported price. Read footnotes for ranges.
% of reported position traded
0.69%This security and ownership context
Holdings after
1,045,131Indirect · James N. Wilson and Pamela D. Wilson Trust
Trade date
Nov 13, 2026Sell
Filed
Nov 17, 2026, 4:30 PM ET4-day reporting delay
Accession
0001193125-26-465604Code S · Transaction 403554
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,052,352 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 13, 2026Sell2,191$71.80−$157,316.21Trade 403553
Nov 13, 2026Sell563$73.42−$41,335.01Trade 403555
Nov 13, 2026Sell25$74.28−$1,857Trade 403556
4 transaction rows in this filing. Joint filers share the same rows.

CORT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CORT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +66%1w ago +3.9%1d ago +5.2%
Returns since7d30d90d180d1y

Footnotes in full

F1: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction. F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $71.18 to $72.17 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. F3: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $72.18 to $73.155 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. F4: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.22 to $73.88 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. F5: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.